Jonathan Waxman is a Professor of Oncology at the Hammersmith Hospital, London. He is a clinician who has helped develop new treatments for cancer, which are now part of standard practice. He is the author of around 300 research papers and chapters, eleven books on cancer, a novel and a law book.
He directs a laboratory research group comprising 31 scientists whose focus is the development of new cancer treatments and tests. He has raised funds for the building of the Hammersmith Cancer Centre whose spirit aims to combine the best of conventional and alternative therapies.
He founded The Prostate Cancer Charity, the first United Kingdom national organisation promoting research and patient support for this condition which affects 1 man in 12. The Charity currently raises £8 million per annum and employs 65 people.
He helped establish an All Party Parliamentary Group to improve cancer treatment and rationalise cancer research throughout the UK. He has developed and led successful media campaigns to rationalise cancer treatments and change government health policy.
Kypta RM, Waxman J, 2012, Wnt/beta-catenin signalling in prostate cancer, Nature Reviews Urology, Vol:9, ISSN:1759-4812, Pages:418-428